Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST)

Twist Bioscience Corporation (NASDAQ:TWST) is among the 12 Best Genomics Stocks to Invest In.

Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST)

TheFly reported on December 15, 2025, that Barclays kept its Overweight rating and boosted its price objective for Twist Bioscience Corporation (NASDAQ:TWST) from $37 to $39. The move was included in the company’s more comprehensive 2026 outlook report for the life sciences and diagnostics instruments industry. According to Barclays, end markets are rebounding, the last round of estimate cutbacks has mostly passed, and the healthcare industry’s most under-owned sector is still tools. Based on the company’s research note given to investors, all of these factors provide a favorable setting for the tools group to exceed expectations in 2026.

Furthermore, Twist Bioscience Corporation (NASDAQ:TWST) released fiscal 2026 guidance. The business anticipates total revenue to be between $425 million and $435 million, which implies an increase of between 13% and 15.5% year over year. Revenue for the DNA Synthesis and Protein Solutions Group is anticipated to reach $194 million to $199 million, representing a 15% to 18% rise over fiscal 2025. It is projected that the NGS Applications Group will make between $231 million and $236 million, showing a rise of 11% to 13.5%. The fiscal year 2026 gross margin is expected to go above 52%. Apart from that, the firm announced its goal to end fiscal 2026 with adjusted EBITDA breakeven in the fourth quarter.

Twist Bioscience Corporation (NASDAQ:TWST) is a synthetic biology business that has created a disruptive DNA synthesis platform to industrialize biological engineering.

While we acknowledge the risk and potential of TWST as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TWST and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025.

Disclosure. None